Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of ...
First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance Preparations for dose-ranging Phase 2 study of NPM-139 to occur in parallel with Phase 1 ...
Cybersecurity researchers have discovered a malicious npm package named "@acitons/artifact" that typosquats the legitimate " ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback